Park Ha Biological Technology Co., Ltd. (BYAH)
NASDAQ: BYAH · Real-Time Price · USD
1.840
+0.140 (8.24%)
At close: Feb 27, 2026, 4:00 PM EST
1.820
-0.020 (-1.09%)
After-hours: Feb 27, 2026, 7:58 PM EST

BYAH Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Oct '24 Oct '23 Oct '22 Oct '21
Revenue
2.772.382.461.920.93
Revenue Growth (YoY)
42.65%-3.14%28.12%106.16%-
Cost of Revenue
0.160.20.310.510.31
Gross Profit
2.612.192.151.410.62
Selling, General & Admin
21.431.180.781.151.12
Research & Development
0.040.040.030.06-
Operating Expenses
21.631.390.971.211.12
Operating Income
-19.010.791.180.2-0.5
Interest Expense
-0---0-0
Interest & Investment Income
00000
Other Non Operating Income (Expenses)
0.06-0-0-0.010.02
Pretax Income
-18.960.791.180.19-0.48
Income Tax Expense
0.450.310.33-0-
Net Income
-19.410.480.850.19-0.48
Net Income to Common
-19.410.480.850.19-0.48
Net Income Growth
--43.83%345.40%--
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
EPS (Basic)
-37.400.961.700.38-0.97
EPS (Diluted)
-37.400.961.700.38-1.00
EPS Growth
--43.83%345.40%--
Free Cash Flow
1.090.870.11.43-0.51
Free Cash Flow Per Share
2.101.750.212.86-1.02
Gross Margin
94.37%91.80%87.35%73.47%66.58%
Operating Margin
-686.90%33.32%48.01%10.27%-53.81%
Profit Margin
-701.07%20.09%34.65%9.97%-52.09%
Free Cash Flow Margin
39.34%36.73%4.22%74.52%-54.86%
EBITDA
-18.990.821.20.23-0.46
EBITDA Margin
-34.28%48.82%11.85%-49.62%
D&A For EBITDA
0.030.020.020.030.04
EBIT
-19.010.791.180.2-0.5
EBIT Margin
-33.32%48.01%10.27%-53.81%
Effective Tax Rate
-39.68%27.89%--
Advertising Expenses
-00-0.04
Source: S&P Capital IQ. Standard template. Financial Sources.